| NCT ID | NCT06526585 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Stress |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-03-12 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test the immediate and long term (post 4 weeks of daily practice) effectiveness of two breathwork practices, cyclic sighing and box breathing, in comparison to hypnosis and an audiobook about stress, on psychological and physiological variables.
Eligibility Criteria
Inclusion Criteria: * Age 18 or older * No contraindications to MRI imaging (like ferromagnetic metal in their body) Exclusion Criteria: * Pregnant or planning to get pregnant during study participation. * Not able or willing to come to research location twice for MRI assessments
Contact & Investigator
David Spiegel, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT06526585 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06526585 currently recruiting?
Yes, NCT06526585 is actively recruiting participants. Contact the research team at bita@stanford.edu for enrollment information.
Where is the NCT06526585 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT06526585 clinical trial?
NCT06526585 is sponsored by Stanford University. The principal investigator is David Spiegel, MD at Stanford University. The trial plans to enroll 80 participants.